Birchview Capital »

Corcept Therapeutics Incorporated shares owned by Birchview Capital

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Birchview Capital from 13F filings

Historical chart of Birchview Capital investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Birchview Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.4M 74k 32.49
2024-03-31 $1.3M 50k 25.19
2023-12-31 $1.6M 50k 32.48
2023-09-30 $1.4M 50k 27.25
2023-06-30 $1.1M 50k 22.25
2023-03-31 $1.1M 50k 21.66
2022-12-31 $1.0M 50k 20.32
2022-09-30 $1.3M 50k 25.64
2022-06-30 $1.2M 50k 23.78
2022-03-31 $1.1M 50k 22.52
2021-12-31 $990k 50k 19.80
2021-09-30 $984k 50k 19.68
2021-06-30 $1.1M 50k 22.00
2021-03-31 $1.2M 50k 23.80
2020-12-31 $1.3M 50k 26.16
2020-09-30 $870k 50k 17.40
2020-06-30 $841k 50k 16.82
2020-03-31 $594k 50k 11.88
2019-12-31 $605k 50k 12.10
2019-09-30 $707k 50k 14.14
2019-06-30 $558k 50k 11.16
2019-03-31 $587k 50k 11.74
2018-12-31 $668k 50k 13.36
2018-09-30 $701k 50k 14.02
2018-06-30 $786k 50k 15.72
2018-03-31 $1.2M 76k 16.45
2017-12-31 $1.7M 95k 18.06
2017-09-30 $1.8M 95k 19.31
2017-06-30 $1.1M 95k 11.80
2017-03-31 $658k 60k 10.97
2016-12-31 $581k 80k 7.26
2016-09-30 $520k 80k 6.50
2016-06-30 $437k 80k 5.46
2016-03-31 $374k 80k 4.68
2015-12-31 $398k 80k 4.98

More positions owned by Birchview Capital

Bristol Myers Squibb (BMY)
Biodesix (BDSX)
Aziyo Biologics (ELUT)
Neurocrine Biosciences (NBIX)
Silk Road Medical Inc Common
Prothena Corp SHS (PRTA)
ACADIA Pharmaceuticals (ACAD)
Encana Corporation (OVV)
United Therapeutics Corporation (UTHR)
Harrow Health (HROW)
Stoke Therapeutics (STOK)
Phreesia (PHR)
Corcept Therapeutics Incorporated (CORT)
Quidel Corporation
Masimo Corporation (MASI)

View all positions for Birchview Capital

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
Dimensional Fund Advisors
Novo A/S
Geode Capital Management
Btim
Arrowstreet Capital, Limited Partnership
Morgan Stanley
Charles Schwab Investment Management
D. E. Shaw & Co
Jacobs Levy Equity Management

View all funds holding Corcept Therapeutics Incorporated